FDA Greenlights Kythera’s Kybella
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
In a much anticipated approval, the FDA has given its nod to Kythera's Kybella to treat double chins.
Presentations highlight investigational trenibotulinumtoxinE in the treatment of glabellar lines and other new findings across the company's portfolio.